Arcoma AB (OSTO:ARCOMA) Operating Margin %: 3.00% (As of Mar. 2026) — 12% Above Median


OSTO:ARCOMA Arcoma AB OSTO:ARCOMA
75 GF Score
Price kr8.50
GF Value kr7.85
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Arcoma AB Operating Margin %?

Arcoma AB OSTO:ARCOMA 75 Operating Margin % is 3.00% as of Mar. 2026, which is 12% above its 10-year median of 2.68. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.85 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Arcoma AB ranks better than 50.61% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Arcoma AB's Operating Income for the three months ended in Mar. 2026 was kr0.9 Mil. Arcoma AB's Revenue for the three months ended in Mar. 2026 was kr31.1 Mil. Therefore, Arcoma AB's Operating Margin % for the quarter that ended in Mar. 2026 was 3.00%.

The historical rank and industry rank for Arcoma AB's Operating Margin % or its related term are showing as below:

OSTO:ARCOMA' s Operating Margin % Range Over the Past 10 Years
Min: -12.43   Med: 2.68   Max: 8.71
Current: 3.61


OSTO:ARCOMA's Operating Margin % is ranked better than
50.61% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs OSTO:ARCOMA: 3.61

Arcoma AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Arcoma AB's Operating Income for the three months ended in Mar. 2026 was kr0.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr4.6 Mil.


Arcoma AB  (OSTO:ARCOMA) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Arcoma AB Operating Margin % Related Terms


Arcoma AB Operating Margin % Historical Data

* Premium members only.

The historical data trend for Arcoma AB's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcoma AB Operating Margin % Chart

Arcoma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.36 2.50 2.86 8.71 4.77

Arcoma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.42 0.06 6.55 4.82 3.00

OSTO:ARCOMA vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, Arcoma AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcoma AB Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Arcoma AB's Operating Margin % falls into.


OSTO:ARCOMA
75GF Score
Arcoma AB OSTO:ARCOMA
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcoma AB Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Arcoma AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=6.236 / 130.8
=4.77 %

Arcoma AB's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=0.935 / 31.131
=3.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 3.00% mean?
Arcoma AB (OSTO:ARCOMA) has a Operating Margin % of 3.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Arcoma AB and its competitors. This is 12% above median its historical median of 2.68. According to the industry distribution chart, Arcoma AB ranks #403 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 49.4%.
Is Arcoma AB's Operating Margin % too high?
Arcoma AB's current Operating Margin % of 3.00% is 12% above median its 10-year median of 2.68. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Arcoma AB's value of 3.00% is 13.4% below this industry median. Based on the distribution chart, Arcoma AB ranks #403 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #403 out of 816 companies for Operating Margin %. This puts Arcoma AB in the upper half of its industry. The industry median Operating Margin % is 3.47. Arcoma AB's value of 3.00% is 13.4% below this benchmark. While the company's 10-year median is 2.68 vs. the industry median of 3.47, Arcoma AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcoma AB's current Operating Margin % of 3.00% is 13.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Arcoma AB and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcoma AB's current Operating Margin % is 3.00%, which is 12% above median its own 10-year median of 2.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.85, compared to a current price of kr8.50 — trading 8.3% above its estimated fair value. The current Operating Margin % is 3.00%, which is 12% above median its 10-year median of 2.68 and 13.4% below the Medical Devices & Instruments industry median of 3.47. Arcoma AB's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Operating Margin % is 3.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued. The current stock price of kr8.50 is trading 8.3% above its estimated GF Value™ of kr7.85. GuruFocus considers Arcoma AB to be Fairly Valued.

Key valuation signals for OSTO:ARCOMA:

  • Operating Margin %: 3.00% (12% above median its 10-year median of 2.68)
  • GF Value™: kr7.85 vs. price of kr8.50 (8.3% above fair value)
  • GF Score™: 75/100 with 4 warning signs
  • Industry Position: 13.4% below the Medical Devices & Instruments median (#403 of 816)

No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arcoma AB Business Description

Address Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score

Get the complete analysis for OSTO:ARCOMA

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.50
Price
kr7.85
GF Value